.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Cerilliant
Baxter
Merck
Fuji
Julphar
Deloitte
Medtronic
Accenture
Moodys

Generated: July 23, 2017

DrugPatentWatch Database Preview

Flurbiprofen sodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for flurbiprofen sodium and what is the scope of flurbiprofen sodium freedom to operate?

Flurbiprofen sodium
is the generic ingredient in two branded drugs marketed by Allergan and Bausch And Lomb, and is included in two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for flurbiprofen sodium. Four suppliers are listed for this compound.

Summary for Generic Name: flurbiprofen sodium

Tradenames:2
Patents:1
Applicants:2
NDAs:2
Drug Master File Entries: see list11
Suppliers / Packagers: see list4
Bulk Api Vendors: see list9
Clinical Trials: see list2,391
Patent Applications: see list3
Therapeutic Class:Ophthalmic Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:flurbiprofen sodium at DailyMed

Pharmacology for Ingredient: flurbiprofen sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb
FLURBIPROFEN SODIUM
flurbiprofen sodium
SOLUTION/DROPS;OPHTHALMIC074447-001Jan 4, 1995ATRXNoNo► Subscribe► Subscribe
Allergan
OCUFEN
flurbiprofen sodium
SOLUTION/DROPS;OPHTHALMIC019404-001Dec 31, 1986ATRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: flurbiprofen sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan
OCUFEN
flurbiprofen sodium
SOLUTION/DROPS;OPHTHALMIC019404-001Dec 31, 19863,755,427► Subscribe
Allergan
OCUFEN
flurbiprofen sodium
SOLUTION/DROPS;OPHTHALMIC019404-001Dec 31, 19863,793,457► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Healthtrust
Novartis
Cipla
Citi
Cantor Fitzgerald
Teva
Boehringer Ingelheim
Chinese Patent Office
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot